Real-life safety and efficacy of omalizumab in Japanese patients with severe allergic asthma who were subjected to dosing table revision or expansion: A post-marketing surveillance

Publication date: Available online 17 September 2020Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Koichiro Asano, Kazuya Sumi, Hajime Yoshisue, Noriko Nakamura, Makoto Nagasaki, Takayoshi Sasajima, Hisako Matsumoto
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research